Pharmacokinetics Study of FIA586 in Participants With Mild and Moderate Hepatic Impairment
Clinical trial NCT04993157 · COMPLETED
Trial details
- NCT number
- NCT04993157
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-10
- Primary completion
- 2022-06-28
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.